October 26, 2021
University of California San Diego researchers describe how a pair of fundamental genetic and cellular processes — aneuploidy and unfolded protein response — are exploited by cancer cells to promote tumor survival and growth.
June 17, 2024
U.S. News & World Report has unveiled its 2024 Best Graduate Schools rankings in Engineering and in Pharmacy, spotlighting the UC San Diego Jacobs School of Engineering and Skaggs School of Pharmacy and Pharmaceutical Sciences as among the top in the nation.
January 13, 2020
University of California San Diego School of Medicine researchers identified how THC from marijuana accelerates cancer growth in patients with human papillomavirus (HPV)-positive head and neck cancer.
May 10, 2018
…a particular type of immunotherapy that is used for other types of cancers, but is not standard treatment for basal cell carcinoma. They believed the drug would help Lyon because previous studies suggested it was effective against other cancers with genetic mutations similar to his. It worked. Today, Lyon’s tumors…
October 4, 2016
Four biologists, a nanoengineer and a biophysicist at UC San Diego today received a total of more than $5 million in grants from the National Institutes of Health to pursue innovative and transformative research projects.
October 21, 2020
San Diego-based Cellics Therapeutics, which was co-founded by UC San Diego nanoengineering Professor Liangfang Zhang, has received an award of up to $15M to develop a macrophage cellular nanosponge—nanoparticles cloaked in the cell membranes of macrophages—designed to treat sepsis.
February 21, 2024
Innovations in the form of multi-scale sensors and devices, creation of humanoid avatars and the development of exceptionally realistic predictive models driven by AI can radically change our lifestyles and response to pathologies.
September 21, 2020
Moores Cancer Center at UC San Diego Health is using advanced imaging, genomics, personalized medicine and new therapies to treat patients like Brian McCloskey, who has stage IV prostate cancer.
December 30, 2019
Researchers report that accumulating amyloid protein occurred faster among persons deemed to have “objectively-defined subtle cognitive difficulties” (Obj-SCD) than among persons considered to be “cognitively normal,” offering a potential new early biomarker for Alzheimer’s disease.
February 6, 2024
Moores Cancer Center continues to bring state-of-the-art cancer treatments from the bench to the bedside.
